Lung cancer screening intervals based on cancer risk

被引:4
|
作者
Zhang, Li [1 ,2 ]
Yip, Rowena [2 ]
Jirapatnakul, Artit [2 ]
Li, Meng [1 ,2 ]
Cai, Qiang [2 ,3 ]
Henschke, Claudia, I [2 ,4 ]
Yankelevitz, David F. [2 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Dept Diagnost Radiol, Natl Canc Ctr, Natl Clin Res Ctr,Canc Canc Hosp, Beijing 100021, Peoples R China
[2] Icahn Sch Med Mt Sinai, Dept Radiol, New York, NY 10029 USA
[3] Shanxi Prov Peoples Hosp, Dept Radiol, Taiyuan 030012, Shanxi, Peoples R China
[4] Vet Adm Hlth Care Syst, Phoenix, AZ USA
关键词
Volume doubling time; Tumor aggressiveness; Risk prediction model; CT screening; PULMONARY NODULES; CT; TRIAL; MORTALITY; PROBABILITY; BENEFITS;
D O I
10.1016/j.lungcan.2020.09.013
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: As low-dose CT screening is gaining acceptance, focus is on increasing the efficiency of screening. One major consideration is to reduce the total number of annual rounds by increasing the interval between screening rounds. It has been suggested that longer intervals could be used for individuals who are at lower risk of lung cancer. In this study, we explored whether eligible participants in a program of LDCT screening who are at lower risk of lung cancer have less aggressive cancers than those at higher risk. Methods: We retrospectively identified 118 participants in I-ELCAP database between 1992-2019 who had been screened using HIPAA-compliant protocols and had solid lung cancers diagnosed on an annual round of screening, 7-18 months after the prior round. Volume doubling time (VDT) for each cancer was calculated. Estimated risk of developing lung cancer was calculated using PLCOM2012 model. The strength of the relationship between VDT and individual PLCOM2012 scores was assessed by Pearson(r) and Spearman (rho) correlation coefficients. Results: VDTs were significantly different by cell-type (p < 0.0001); median VDT for small cell was 34.0 days, followed by other cell-types (61.8 days), squamous-cell (73.3 days), and adenocarcinoma (135.7 days). The median VDT for the 78 (66.1 %) Stage I lung cancers was significantly longer than the 40 Stage II + lung cancers (101.4 days vs. 45.5 days, p < 0.0001). None of the established lung cancer risk indicators (age, pack-years of smoking, or PLCOM2012 scores) were significant predictors of VDT or lung cancer stage. Conclusion: No significant relationship was demonstrated between risk of developing lung cancer (measured by risk models, age or smoking history) and lung cancer aggressiveness (measured by VDT, cell-type and Stage). This suggests that there is no evidence for determining intervals between repeat screenings using risk-based characteristics. It does not, however, exclude the possibility that future models may establish such a relationship.
引用
收藏
页码:113 / 119
页数:7
相关论文
共 50 条
  • [31] Estimation of the Risk of Lung Cancer in Women Participating in a Population-Based Breast Cancer Screening Program
    Gonzalez-Marron, Adrian
    Carlos Martin-Sanchez, Juan
    Garcia-Alemany, Ferran
    Martinez-Martin, Encarna
    Matilla-Santander, Nuria
    Cartanya-Hueso, Aurea
    Vidal, Carmen
    Garcia, Montse
    Martinez-Sanchez, Jose M.
    [J]. ARCHIVOS DE BRONCONEUMOLOGIA, 2020, 56 (05): : 277 - 281
  • [32] Lung cancer screening in high risk populations: Developing community based screening and navigation program
    Pasquinelli, Mary
    Watson, Karriem
    Grumeretz, Scott
    Feldman, Lawrence E.
    Kovitz, Kevin
    Dudek, Arkadiusz Z.
    Menchaca, Martha
    Koshy, Matthew
    Winn, Robert
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2017, 26 (02)
  • [33] Community based lung cancer screening program: Evaluation of the initial lung cancer screening CT scan
    Mishra, Tripurari
    Hakimian, Ari
    Vercillo, Michael
    Joob, Axel
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [34] Association of Lung Cancer Risk With the Presence of Both Lung Nodules and Emphysema in a Lung Cancer Screening Trial
    Liu, Ya
    Feng, Zhuo Wei
    Liu, Xiao Min
    Duan, Hong Yuan
    Lyu, Zhang Yan
    Huang, Yu Bei
    Song, Fang Fang
    Song, Feng Ju
    [J]. WORLD JOURNAL OF ONCOLOGY, 2024, 15 (02) : 246 - 256
  • [35] A Comparative Modeling Analysis of Risk-Based Lung Cancer Screening Strategies
    ten Haaf, Kevin
    Bastani, Mehrad
    Cao, Pianpian
    Jeon, Jihyoun
    Toumazis, Iakovos
    Han, Summer S.
    Plevritis, Sylvia K.
    Blom, Erik F.
    Kong, Chung Yin
    Tammemagi, Martin C.
    Feuer, Eric J.
    Meza, Rafael
    de Koning, Harry J.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2020, 112 (05) : 466 - 479
  • [36] Risk-based lung cancer screening performance in a universal healthcare setting
    Tammemaegi, Martin C.
    Darling, Gail E.
    Schmidt, Heidi
    Walker, Meghan J.
    Langer, Deanna
    Leung, Yvonne W.
    Nguyen, Kathy
    Miller, Beth
    Llovet, Diego
    Evans, William K.
    Buchanan, Daniel N.
    Espino-Hernandez, Gabriela
    Aslam, Usman
    Sheppard, Amanda
    Lofters, Aisha
    Mcinnis, Micheal
    Dobranowski, Julian
    Habbous, Steven
    Finley, Christian
    Luettschwager, Marianne
    Cameron, Erin
    Bravo, Caroline
    Banaszewska, Anna
    Creighton-Taylor, Katherin
    Fernandes, Brenda
    Gao, Julia
    Lee, Alex
    Lee, Van
    Pylypenko, Bogdan
    Yu, Monica
    Svara, Erin
    Kaushal, Shivali
    Macniven, Lynda
    Mcgarry, Caitlin
    Della Mora, Lauren
    Koen, Liz
    Moffatt, Jessica
    Rey, Michelle
    Yurcan, Marta
    Bourne, Laurie
    Bromfield, Gillian
    Coulson, Melissa
    Truscott, Rebecca
    Rabeneck, Linda
    [J]. NATURE MEDICINE, 2024, 30 (03) : 1054 - 1064
  • [37] Lung Cancer Screening Based on Personal Risk May Save More Lives
    Printz, Carrie
    [J]. CANCER, 2018, 124 (07) : 1315 - 1315
  • [38] Cardiovascular Risk Prediction in a Community-Based Lung Cancer Screening Programme
    Balata, H.
    Evison, M.
    Booton, R.
    Crosbie, P.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S780 - S780
  • [39] Community-based lung cancer screening navigation for populations at high risk
    Tsosie, Ursula
    DeCell, Katie
    Anderson, Nicolas
    Snidarich, Madison
    Omernik, Brandon
    Murphy, Nicholas
    Triplette, Matthew
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2024, 33 (09)
  • [40] Increased Risk of Lung Cancer among Women with Superficial TCC: A Potential Risk Cohort for Lung Cancer Screening
    Tolwin, Yaakov
    Rosenbaum, Eli
    Peled, Nir
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S464 - S465